Ketanserin
In clinical developmentAlso known as ketanserina.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Neurobiological Effect of 5-HT2AR Modulation
Effect of Ketanserin After LSD Administration on the Acute Response to LSD in Healthy Subjects
Ketanserin Effects on Peripheral Temperature and Lactate (KoPTaL)
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Ketanserin Effects on Peripheral Temperature and Lactate (KoPTaL)
Recent completions
Trials that read out recently, adding to the completed evidence base.
Effect of Ketanserin After LSD Administration on the Acute Response to LSD in Healthy Subjects
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology1
- Borgwardt S1
- Dolder P1
- Duthaler U1
- Eckert A1
- Holze F1
- Ley L1
- Liechti ME1
- Müller F1
- Department of Biomedicine and Department of Clinical Research1
- Psychiatric University Hospital1
- University of Basel1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Frequently co-studied with Ketanserin in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials